Citations

Showing 10 of 108152 citations.

Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration
Bejanin, Alexandre , Murray, Melissa E. , Martin, Peter R. , Botha, Hugo , Tosakulwong, Nirubol , Senjem, Matthew L. , Chételat, Gaël , Kantarci, Kejal , Jack, Clifford R. , Knopman, David S. , Petersen, Ronald , Parisi, Joseph E., Whitwell, Jennifer L. , Josephs, Keith A. , Jack, Clifford R , Senjem, Matthew L , Bejanin, Alexandre , Kantarci, Kejal , Botha, Hugo , Murray, Melissa E , Schwarz, Christopher G. , Boeve, Bradley F. , Knopman, David S. , Giannini, Caterina , Dickson, Dennis W.

Mayo Clinic

Brain | September 4, 2019 | Volume: 142 | Issue: 11 | Pages: 3621-3635

10.1093/brain/awz277 | PMID 31562527 Get It

The specific effect of TDP-43 pathology on grey matter volume in individuals without frontotemporal lobar degeneration is unclear. Bejanin et al. reveal a major and independent contribution of TDP-43 to neurodegeneration and shed light on the regional distribution of TDP-43-related atrophy in older adults.
Urinary extracellular vesicle analysis and detection of low abundance immunoglobulin oligomers in samples isolated from patients with significant urine proteinuria
Cooper, Shawna A. , Dick, Christopher J., Cooper, Shawna A , Misra, Pinaki , Leung, Nelson , Schinstock, Carrie A. , Ramı́rez-Alvarado, Marina

Mayo Clinic

No container title available | September 4, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.13477/v1 Get It

Abstract Urinary extracellular vesicles (uEVs) have been used as a biomarker tool for detection of low abundance immunoglobulin-based targets in uEVs with heterogeneous high protein mixtures. This protocol outlines a pre-incubation method to minimize non-specific secondary antibody binding. Additionally, we include our approach for standardization of uEV amounts used for sample comparison. We propose that these and knowledge of the detection limit for target proteins are strategies applicable to other laboratories working with complex heterogeneous samples.
Return to Duty After Mini‐Open Arthroscopic‐Assisted Treatment of Femoroacetabular Impingement in an Active Military Population
Song, Daniel J. , Lee, Gregory Y., Tokish, John M. , Ernat, Justin J. , Cage, J. Matthew

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | September 4, 2019 | Volume: 1 | Issue: 1 | Pages: No page available

10.1016/j.asmr.2019.07.003 | PMID 32267252 Get It

Purpose To report the return‐to‐duty rate and surgical outcomes in a military population after mini‐open arthroscopic‐assisted surgery for femoroacetabular impingement (FAI) in an effort to affirm its efficacy. Methods A retrospective review of consecutive active‐duty patients receiving mini‐open arthroscopic‐assisted surgery for FAI between 2007 and 2011 was performed. Patients younger than 18 years, non–active‐duty patients, and patients with prior hip surgery were excluded. Demographic, radiographic, and duty‐status data were collected. The primary outcome measure was a return to duty. Outcome scores were obtained in a proportion of the cohort, including the modified Harris Hip Score, Single Assessment Numeric Evaluation score, Western Ontario and McMaster Universities Osteoarthritis Index score, patient satisfaction score, and Veterans RAND 12 (VR‐12) score. All patients had achieved a minimum of 1 year of follow‐up at the time of assessment. All P values for significance were set at .05 or lower. Results Of 182 patients (average age, 30.4 years), 156 (86%) were available for follow‐up with return‐to‐duty data at an average of 2.8 years (range, 1‐6 years). Of the patients, 78% returned to full duty (53%) or returned to duty with restrictions (25%). Outcome scores were available for 101 of 182 patients (55%) with duty rates similar to the total cohort (81% who returned to duty: 58% with no restrictions and 23% with restrictions). Return to duty correlated with improved outcomes compared with those who were medically discharged with respect to the modified Harris Hip Score (68.2 vs 54.5, P < .03), Single Assessment Numeric Evaluation score (48.2 vs 25.3, P < .02), and VR‐12 physical (39.7 vs 33.2, P < .05) and VR‐12 mental (54.5 vs 43.4, P < .005) scores. Conclusions Mini‐open arthroscopic‐assisted surgery for FAI is successful in returning most service members to duty at short‐term follow‐up. Return correlates with improved outcome scores, although previously reported minimally clinical important difference and patient acceptable symptomatic state threshold values were not uniformly achieved. Level of Evidence Level IV, retrospective case series.
Increased plasma levels of 8‐oxoguanine DNA glycosylase‐1 in bipolar disorder
Ceylan, Deniz , Yılmaz, Selda, Bora, Uğur, Tuna, Gamze , Ildız, Ayşegül, Akan, Pınar , Frye, Mark A. , Özerdem, Ayşegül , Ozerdem, Aysegul , Veldić, Marin , Ceylan, Deniz

Mayo Clinic

Psychiatry and Clinical Neurosciences | September 4, 2019 | Volume: 73 | Issue: 11 | Pages: 719-720

10.1111/pcn.12928 | PMID 31482650 Get It

P: 6 Interaction of Pre-dementia Mild Cognitive Impairment and Hepatic Encephalopathy in Elderly Patients With Cirrhosis: A Multi-Center Study
Xie, Jessie, Acharya, Chathur , Wade, James B. , Kelly, Megan , Fagan, Andrew , White, Melanie B. , Flud, Christopher , Bajaj, Jasmohan S. , Vargas, Hugo E. , Duarte‐Rojo, Andrés , Thacker, Leroy R. , Kelly, Megan, White, Melanie B. , García-Saenz-de-Sicilia, Mauricio

Mayo Clinic

American Journal of Gastroenterology | September 4, 2019 | Volume: 114 | Issue: 1 | Pages: S3-S3

10.14309/01.ajg.0000582000.75174.29 Get It

BACKGROUND: Patients with cirrhosis are growing older and the overlap between hepatic encephalopathy (HE) & pre-dementia mild cognitive impairment (MCI) is unclear. HE affects visuospatial/psychomotor speed while MCI affects memory. Aim: Determine the performance of elderly cirrhotics on tests for HE and dementia and their impact on quality of life (QOL). METHODS: Outpatient cirrhotics and controls ages 65–95 years were recruited at 4 centers. Subjects had to have MMSE > 25, no current HE or dementia to be eligible. All subjects got tests for HE (psychometric hepatic encephalopathy score, PHES: 5 tests & low score = poor, EncephalApp, OffTime + OnTime, high score = poor) and QOL: Sickness Impact profile (SIP, high score = poor QOL). Cirrhotics also got tests for MCI; RBANS (tests immediate memory, delayed memory, language, visuo-spatial & attention). A neuro-psychologist evaluated results and divided cirrhotics into (A) unimpaired (B) MCI only (C) HE only & (D) (MCI/HE overlap). Demographics, MELD, alcohol etiology, and SIP were compared. Finally, age, gender and education-adjusted norms were created for PHES and EncephalApp based on the controls. Presence of MHE and sensitivity of EncephalApp for MHE diagnosis were evaluated. RESULTS: 109 cirrhotics and 100 non-cirrhotic subjects were included. Demographics/education levels were statistically similar between centers. Controls were older than cirrhotics (74.9 ± 6.6 vs 70.5 ± 4.4, P < 0.05) and had similar education/gender distribution. Despite this, controls performed better than cirrhotics on all tests (PHES 2.9 ± 12.4 vs −4.5 ± +4.5, P < 0.001, EncephalApp Off+On 181.4 ± +71.9 vs 218.2 ± +80.0, P = 0.03) and had a better QOL (SIP total 3.8 ± +7.1 vs 7.9 ± +9.5, Psych 3.3 ± +8.4 vs 7.2 ± +11.1, Phys 3.0 ± +6.2 vs 6.7 ± +9.5, all P < 0.001). Within cirrhosis subgroups (Table 1), demographics, MELD/alc & MMSE were similar. Pts with both MCI/HE had worse cognition on all tests, which translated into a worse QOL compared to other groups. Presence of HE, with/without MCI, contributed towards poor QOL. Norms for PHES/EncephalApp: Adjusting for age, gender & education, 17% (n = 17) patients were positive for MHE on PHES compared to controls. On EncephalApp, 49% (n = 47) patients were positive. AUC for EncephalApp using PHES as the gold standard was 0.86 (0.78-0.95 CI). CONCLUSIONS: In this multi-center study, adjusted norms defining the high sensitivity of EncephalApp to diagnose HE in older individuals were created. Presence of HE regardless of MCI contributed towards poor cognition and QOL in patients >65 years.
Proteomics in gastroparesis: unique and overlapping protein signatures in diabetic and idiopathic gastroparesis
Grover, Madhusudan , Dasari, Surendra , Bernard, Cheryl E., Chikkamenahalli, Lakshmikanth L., Yates, Katherine P. , Pasricha, Pankaj J. , Sarosiek, Irene , McCallum, Richard W. , Koch, Kenneth L. , Shulman, Robert J. , McKenzie, Travis J. , Kellogg, Todd A., Kendrick, Michael L. , Tonascia, James , Hamilton, Frank A., Farrugia, Gianrico , Rothberg, Amy E. , Gibbons, S J , Farrugia, Gianrico , Abell, Thomas L. , Kuo, Braden , Gibbons, Simon J. , Parkman, Henry P.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | September 4, 2019 | Volume: 317 | Issue: 5 | Pages: G716-G726

10.1152/ajpgi.00115.2019 | PMID 31482734 Get It

Macrophage-based immune dysregulation plays a critical role in development of delayed gastric emptying in diabetic mice. Loss of anti-inflammatory macrophages and increased expression of genes associated with pro-inflammatory macrophages has been reported in full-thickness gastric biopsies from gastroparesis patients. We aimed to determine broader protein expression (proteomics) and protein-based signaling pathways in gastric biopsies of diabetic (DG) and idiopathic gastroparesis (IG) patients. Additionally, we determined correlations between protein expressions, gastric emptying, and symptoms. Full-thickness gastric antrum biopsies were obtained from nine DG patients, seven IG patients, and five nondiabetic controls. Aptamer-based SomaLogic tissue scan that quantitatively identifies 1,305 human proteins was used. Protein fold changes were computed, and differential expressions were calculated using Limma. Ingenuity pathway analysis and correlations were carried out. Multiple-testing corrected P < 0.05 was considered statistically significant. Seventy-three proteins were differentially expressed in DG, 132 proteins were differentially expressed in IG, and 40 proteins were common to DG and IG. In both DG and IG, “Role of Macrophages, Fibroblasts and Endothelial Cells” was the most statistically significant altered pathway [DG false discovery rate (FDR) = 7.9 × 10−9; IG FDR = 6.3 × 10−12]. In DG, properdin expression correlated with GCSI bloating ( r = −0.99, FDR = 0.02) and expressions of prostaglandin G/H synthase 2, protein kinase C-ζ type, and complement C2 correlated with 4 h gastric retention ( r = −0.97, FDR = 0.03 for all). No correlations were found between proteins and symptoms or gastric emptying in IG. Protein expression changes suggest a central role of macrophage-driven immune dysregulation in gastroparesis, specifically, complement activation in diabetic gastroparesis. NEW & NOTEWORTHY This study uses SOMAscan, a novel proteomics assay for determination of altered proteins and associated molecular pathways in human gastroparesis. Seventy-three proteins were changed in diabetic gastroparesis, 132 in idiopathic gastroparesis compared with controls. Forty proteins were common in both. Macrophage-based immune dysregulation pathway was most significantly affected in both diabetic and idiopathic gastroparesis. Proteins involved in the complement and prostaglandin synthesis pathway were associated with symptoms and gastric emptying delay in diabetic gastroparesis.
Association between serum uric acid and chronic kidney disease in patients with hypertension: A multicenter nationwide cross‐sectional study
Kaewput, Wisit , Thongprayoon, Charat , Ruangkanchanasetr, Prajej , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Kaewput, Wisit , Thongprayoon, Charat , Rangsin, Ram , Mao, Michael A.

Mayo Clinic

Journal of Evidence-Based Medicine | September 4, 2019 | Volume: 12 | Issue: 4 | Pages: 235-242

10.1111/jebm.12364 | PMID 31482688 Get It

AbstractIntroductionCurrent data on the role of hyperuricemia as a risk factor for renal progression in patients with hypertension is inconclusive. This study aimed to assess the association of uric acid and chronic kidney disease (CKD) in hypertensive patients using a nationwide patient sample.MethodsWe conducted a nationwide cross‐sectional study based on the DM/HT study of the Medical Research Network of the Consortium of Thai Medical Schools.This study evaluated adult patients with hypertension from 831 Thailand public hospitals in the year 2014. Serum uric acid (SUA) was categorized into quintiles (≤4.5, 4.6 to 5.4, 5.5 to 6.2, 6.3 to 7.4, ≥7.5 mg/dL). CKD was defined as estimated glomerular filtration rate of ≤ 60 mL/min/1.73 m2. Multivariate logistic regression was performed to assess the association between SUA and CKD using uric acid of ≤4.5 mg/dL as the reference group.ResultsA total of 9776 hypertensive patients with available SUA were included in the analysis. The mean SUA was 6.1±1.8 mg/dL. The prevalence of CKD in hypertensive patients was 31.8%. SUA of 4.6 to 5.4, 5.5 to 6.2, 6.3 to 7.4, and ≥7.5 mg/dL were associated with an increased CKD with ORs of 1.57 (95% CI 1.28 to 1.92), 2.15 (95% CI 1.74 to 2.66), 3.31 (95% CI 2.72 to 4.04), and 7.11 (95% CI 5.76 to 8.78), respectively. The restricted cubic spline showed significant increased CKD prevalence when uric acid ≥4.6 mg/dL.ConclusionHigher SUA was associated with increased CKD prevalence in patients with hypertension. SUA should be monitored in hypertensive patients for CKD prevention.
Left Ventricular Pseudoaneurysm with Fistulization into the Right Atrium: a Complication of Prosthetic Mitral Perivalvular Abscess
Yoo, Jae Suk , Ali, Yehia Z , Kim, Kyung‐Hee , Kim, Kyung-Hee

Mayo Clinic

Journal of Cardiovascular Imaging | September 4, 2019 | Volume: 27 | Issue: 4 | Pages: 290

10.4250/jcvi.2019.27.e44 | PMID 31614403 Get It

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Maurer, Mathew S. , Bokhari, Sabahat , Drachman, Brian, Fontana, Marianna , Grogan, Martha , Kristen, Arnt V. , Lousada, Isabelle , Nativi-Nicolau, José , Ruberg, Frederick L. , Merlini, Giampaolo , Merlini, Giampaolo , Maurer, Mathew S , Damy, Thibaud , Dorbala, Sharmila , Fontana, Marianna , Quarta, Candida Cristina , Rapezzi, Claudio , Witteles, Ronald

Mayo Clinic

Circulation: Heart Failure | September 4, 2019 | Volume: 12 | Issue: 9 | Pages: No page available

10.1161/circheartfailure.119.006075 | PMID 31480867 Get It

Cardiomyopathy is a manifestation of transthyretin amyloidosis (ATTR), which is an underrecognized systemic disease whereby the transthyretin protein misfolds to form fibrils that deposit in various tissues and organs. ATTR amyloidosis is debilitating and associated with poor life expectancy, especially in those with cardiac dysfunction, but a variety of treatment options have recently become available. Considered a rare disease, ATTR amyloidosis may be more prevalent than thought, particularly in older persons. Diagnosis is often delayed because of a lack of disease awareness and the heterogeneity of symptoms at presentation. Given the recent availability of effective treatments, early recognition and diagnosis are especially critical because treatment is likely more effective earlier in the disease course. The Amyloidosis Research Consortium recently convened a group of experts in ATTR amyloidosis who, through an iterative process, agreed on best practices for suspicion, diagnosis, and characterization of disease. This review describes these consensus recommendations for ATTR associated with cardiomyopathy as a resource to aid cardiologists and others in the recognition and diagnosis of ATTR associated with cardiomyopathy. Included in this review is an overview of red flag signs and symptoms and a recommended diagnostic approach, including testing for monoclonal protein, scintigraphy, or biopsy and, if ATTR associated with cardiomyopathy is identified, TTR genotyping.
Underwater Fear in a Ten-Year-Old Boy
Ziai, Mohsen, Hayles, Alvin B.

Mayo Clinic

Clinical Pediatrics | September 4, 2019 | Volume: 12 | Issue: 4 | Pages: 256-256

10.1177/000992287301200431 Get It